These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29244093)

  • 21. Comparative in vivo degradation of hyaluronic acid-based fillers following injection of hyaluronidase.
    Cavallini M; Pierce A; Nakab L
    J Cosmet Dermatol; 2024 Jan; 23(1):356-357. PubMed ID: 37461249
    [No Abstract]   [Full Text] [Related]  

  • 22. Degradation of Hylauronic Acid Fillers Using Hyaluronidase in an In Vivo Model.
    Ferraz RM; Sandkvist U; Lundgren B
    J Drugs Dermatol; 2018 May; 17(5):548-553. PubMed ID: 29742187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective in vivo evaluation of three different hyaluronic acid gels to varying doses of hyaluronidase with long-term follow-up.
    Zhang-Nunes S; Ryu C; Cahill K; Straka D; Nabavi C; Czyz C; Foster J
    J Plast Reconstr Aesthet Surg; 2021 Apr; 74(4):874-880. PubMed ID: 33281083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe vision loss caused by cosmetic filler augmentation: Case series with review of cause and therapy.
    Thanasarnaksorn W; Cotofana S; Rudolph C; Kraisak P; Chanasumon N; Suwanchinda A
    J Cosmet Dermatol; 2018 Oct; 17(5):712-718. PubMed ID: 30006992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-linked hyaluronic acid filler hydrolysis with hyaluronidase: Different settings to reproduce different clinical scenarios.
    Rauso R; Zerbinati N; Franco R; Chirico F; Ronchi A; Sesenna E; Colella G; Tartaro G
    Dermatol Ther; 2020 Mar; 33(2):e13269. PubMed ID: 32061001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rehabilitation of the Dysmorphic Lower Eyelid From Hyaluronic Acid Filler: What to Do After a Good Periocular Treatment Goes Bad.
    Skippen B; Baldelli I; Hartstein M; Casabona G; Montes JR; Bernardini F
    Aesthet Surg J; 2020 Jan; 40(2):197-205. PubMed ID: 30877762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late onset hypersensitivity reaction to hyaluronic acid dermal fillers manifesting as cutaneous and visceral angioedema.
    Alawami AZ; Tannous Z
    J Cosmet Dermatol; 2021 May; 20(5):1483-1485. PubMed ID: 33342068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Retrobulbar Hyaluronidase in Filler-Associated Blindness: Evaluation of Fundus Perfusion and Electroretinogram Readings in an Animal Model.
    Hwang CJ; Mustak H; Gupta AA; Ramos RM; Goldberg RA; Duckwiler GR
    Ophthalmic Plast Reconstr Surg; 2019; 35(1):33-37. PubMed ID: 29877958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyaluronidase: What is your fear?
    Bravo BSF; Bianco S; Bastos JT; Carvalho RM
    J Cosmet Dermatol; 2021 Oct; 20(10):3169-3172. PubMed ID: 34242464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cosmetic Filler Blindness: Recovery After Repeated Hyaluronidase Injections.
    Danks JJ; Dalgliesh JD; Ayton T
    Aesthet Surg J; 2022 Mar; 42(4):411-416. PubMed ID: 34480547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyaluronic acid fillers and hyaluronidase use in regional eye blocks.
    Tan P; Malhotra R; Ali S
    Anaesthesia; 2016 Aug; 71(8):988-9. PubMed ID: 27396266
    [No Abstract]   [Full Text] [Related]  

  • 32. The duration of hyaluronidase and optimal timing of hyaluronic acid (HA) filler reinjection after hyaluronidase injection.
    Kim HJ; Kwon SB; Whang KU; Lee JS; Park YL; Lee SY
    J Cosmet Laser Ther; 2018 Feb; 20(1):52-57. PubMed ID: 29199877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dizziness and Pain After Temporal Augmentation With Hyaluronic Acid.
    Zhuang J; Zheng Q; Hu J
    J Craniofac Surg; 2023 Sep; 34(6):e590-e592. PubMed ID: 37336475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of hyaluronidase in the treatment of complications from hyaluronic acid dermal fillers.
    Cavallini M; Gazzola R; Metalla M; Vaienti L
    Aesthet Surg J; 2013 Nov; 33(8):1167-74. PubMed ID: 24197934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standardized in vitro analysis of the degradability of hyaluronic acid fillers by hyaluronidase.
    Buhren BA; Schrumpf H; Bölke E; Kammers K; Gerber PA
    Eur J Med Res; 2018 Aug; 23(1):37. PubMed ID: 30122153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of Low Doses of Hyaluronidase to Remove Hyaluronic Acid Filler Nodules: A Randomized Clinical Trial.
    Alam M; Hughart R; Geisler A; Paghdal K; Maisel A; Weil A; West DP; Veledar E; Poon E
    JAMA Dermatol; 2018 Jul; 154(7):765-772. PubMed ID: 29710212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Commentary on: Blindness After Facial Filler Injections: The Role of Extravascular Hyaluronidase on Intravascular Hyaluronic Acid Embolism in the Rabbit Experimental Model.
    DeLorenzi C
    Aesthet Surg J; 2020 Feb; 40(3):327-329. PubMed ID: 31942932
    [No Abstract]   [Full Text] [Related]  

  • 38. Novel Treatment of Inadvertent Injection of Postseptal Hyaluronic Acid Filler.
    Master M
    Plast Reconstr Surg; 2021 Nov; 148(5):855e-856e. PubMed ID: 34609999
    [No Abstract]   [Full Text] [Related]  

  • 39. Superselective Arterial Hyaluronidase Thrombolysis Is Not an Effective Treatment for Hyaluronic Acid-Induced Retinal Artery Occlusion: Study in a Rabbit Model.
    Chen J; Ruan J; Wang W; Chen Z; Huang Q; Yang Y; Li J
    Plast Reconstr Surg; 2021 Jan; 147(1):69-75. PubMed ID: 33370052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early hyaluronidase use in preventing skin necrosis after treatment with dermal fillers: Report of two cases.
    Ciancio F; Tarico MS; Giudice G; Perrotta RE
    F1000Res; 2018; 7():1388. PubMed ID: 31001410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.